sudden%20infant%20death%20syndrome
SUDDEN INFANT DEATH SYNDROME
Sudden infant death syndrome (SIDS) is the sudden death of an infant <1 year of age that is unexplained after a systematic investigation of the case as well as performance of a full autopsy, investigation of the death scene and review of the medical history.
Risk factors include sleeping in prone or side position, male infants are more likely to be affected than female infants, perinatal period and beyond age 6 months, sleeping on soft surfaces or bedding, overheating or thermal stress, maternal smoking during pregnancy, young maternal age and pregnancy-related factors (eg inadequate or absence of prenatal care, higher birth order, preterm birth and/or low birth wt).

Sudden%20infant%20death%20syndrome Signs and Symptoms

Definition

  • Sudden death of an infant <1 year that is unexplained after a systematic investigation of the case as well as performance of a full autopsy, investigation of the death scene & review of the medical history

Risk Factors

  • Sleeping in prone or side position has been constantly shown to increase the risk of sudden infant death syndrome (SIDS)
  • Studies show increased occurrence of death in the perinatal period & beyond age 6 months
  • Male patients are more likely to be affected than female patients
  • Sleeping on soft surfaces or bedding
  • Overheating or thermal stress
  • Maternal smoking during pregnancy
  • Young maternal age
  • Pregnancy-related factors (eg inadequate or absence of prenatal care, higher birth order, preterm birth &/or low birth weight)
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
02 Apr 2019
Using preventive zinc and micronutrient powder supplementation does not appear to improve growth in children, a recent study has found.
Roshini Claire Anthony, 28 Sep 2020

A 4-week course of amoxicillin-clavulanate in children with protracted bacterial bronchitis (PBB) does not improve cough resolution rates compared with a 2-week course, according to a study from Australia. However, the longer course may significantly extend time to first cough exacerbation.

Audrey Abella, 14 Oct 2020
Findings from the phase IIa T1GER study revealed the therapeutic potential of the monoclonal antibody golimumab for children and young adults with type 1 diabetes (T1D).